An alternative option is proxy staging of Aβ‐associated tauopathy onset, that is, by defining associations between amyloid PET and tau PET in larger cohorts and extrapolating amyloid PET–based cut‐offs that signal the transition from amyloidosis to tauopathy, considering age and sex as modulating factors. This evidence concerns the gene MAPT and amyloidosis.